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Two forms of the smaller subunit of the human soluble guanylate cyclase enzyme have been cloned by using PCR. One of the clones (IHSGC-I) 
is identical to bovine and rat lung smaller subunit cyclase. However. the other (HSGC-2) is lacking 33 amino acids. Comparison of its sequence 
with published partial genomic sequences of bovine guanylate cyclase indicates that HSGC-2 is formed due to alternative splicing. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
2, I . Oligonucleoticies 
Cyclic GMP is a second messenger found in virtually 
all tissues. It is formed from GTP by guanylate cyclases 
which exist in membrane-bound and soluble forms. The 
soluble syclase (EC 4.6.1.2) is composed of 2 subunits. 
The smaller subunit (619 amino acids) has been previ- 
ously cloned from rat [1] and bovine [Z] lung. Recently 
the larger subunit (691 amino acids) was also cloned 
from bovine lung [3]. Northern blot analysis indicates 
that the enzyme is ubiquitously distributed, being pre- 
sent in tissues such as cerebrum, cerebellum, liver, heart, 
kidney and muscle [ 11. The role of cyclic GMP as intra- 
cellular second messenger is well established for smooth 
muscle, where it acts as a regulator of muscle tone [4]. 
The function of cyclic GMP is also well established in 
the retina, where it participates in visual transduction 
[5]. However, recent findings that nitric oxide (which is 
a potent stimulator of the soluble guanylate cyclase) is 
produced endogenously and that nitric oxide may parti- 
cipate in intracellular and intercellular communica- 
tions, has implicated a wider role for the cyclic GMP 
system [6]. For example, cyclic GMP and nitric oxide 
are suggested to play important roles in neuronal signal- 
ling and in immunomodulation [7]. Previous studies 
have shown that rat and bovine smaller subunits of 
guanylate cyclase are highly conserved [ 1,2] but recent 
studies have also shown that molecular heterogeneity 
may exist in both membrane-bound and soluble forms 
of guanylate cyclase [8]. Using PCR we now report the 
isolation of alternatively spliced forms of the smaller 
subunit of soluble human guanylate cyclase. 
The oligonuclcotidc primers used were specific for previously cloned 
rat and bovine smaller subunit guanylate cyclase. The primers were 
designed ‘with restriction endonuclease linkers EcoRI and BarnHI at 
the 5’ ends to facilitate cloning of amplified fragments: 
Primer 1 5’ CCGGAATTCGGCCTGTACCTGAGTGA- 
CATCCC 
Primer 2 5’ CCGGATCCGTTTCCGAAGAGACAGC- 
GAGGCAT 
2.2.PCR urnpl~Jica~ion qf human guanylule cyciase 
Approximately 2 x IO” phage in 2 ~1 (corresponding to 3 times the 
number of independent phage in library-Clonetech 1066b. human lung 
cDNA) were mixed with 32 ~1 dH,O and freeze-thawed twice. The 
liberated DNA was then subjected to PCR with the specific primers 
described above. The PCR was performed with Gene AMP DNA 
amplification reagent kit from Perkin Elmer Corp. USA, and the 
thermal profile used as 93°C for 30 s, 55°C for 30 s and 72°C for I 
min for a total of 30 cycles. The amplified products were separated by 
agarose gel electrophoresis and cloned into PGEM7Zf(+) vector be- 
tween the ./&RI and &zI&I restriction enzyme sites and sequenced 
by the dideoxy chain termination method [PI. 
3. RESULTS AND DISCUSSION 
Using a strategy based on the polymerase chain reac- 
tion (PCR) and oligonucleotide primers corresponding 
to consensus sequences of rat [I] and bovine [2] soluble 
guanylate cyclase enzymes, we obtained 2 clones 
(HSGC-1 and HSGC-2) encoding the smaller subunit 
of human soluble guanylate cyclase from human lung 
cDNA.. Sequence comparison showed that one of the 
clones (HSGC-1) was completely identical to the nub- 
lished sequences, whereas the other (HSGC-2) was k.ot. 
Alignment of the latter sequence showed that it was 
lacking 33 amino acids (see Fig. 1). 
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HSGC-2 : GLYLSDIP‘R DATRDLVLLG EQFREEYKLT QELEILTDRL QLTLRALEDE 
IIIIIIIIII IIlIIlllI IIIIIIIIII IIIllIIIII IIlIIIIIII 
RSGC-1: GLYLSDIP‘H DATRDLVLLG EQFREEYKLT QELEILTDRL QLTLRALEDE 
IIIII!III! IIIIlIlIII IlIIIIIlII IIIIIIIIII IIIIIIIIII 
R%T-GC: GLYLSDIPLH DATRDLVLLG EQFREEYKLT QELEILTDRL QLTLRAIZDE 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII 
BOV Gc: GLYLSDIPLH DATRDLVLLG EQFREEYKLT QELEILTDRL QLTLRALEDE 
337 386 
"SGC-2: KKKTDT G IVGFNAFCSK 
IIIIII I IIIIIIIIII 
RSGC-1: KKKTDTLLYS “‘PPSVANEL RHKRPVPRKR YDNVTILFSG IVGFNAFCSK 
IIIIIIIIII IIIlIIIIII IIIIIIIIII lIIlIIIIII IIIIIIIIII 
xwm-GC : KKKTDTLLYS “LPPSVANEL RHKRPVPRKR YDNVTILFSG IVGFNAFCSK 
IIIIiIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIll IIIIIIIlII 
BOV-GC: KKKTDTLLYS “LPPSVANEL RHKRPVPAKR YDNVTILFSG IVGFNAFCSK 
387 436 
HSGC-2 : “ASGEGAMKI VNLLNDLYTR FDTLTDSRKN PFVYKVETVG DKYMTVSGLP 
IIIIIlIIII IIIllIIIII IIIIIIIIlI IIIIIIIIII IIIlIIIIII 
HSGC-I : HASGEGAMKI VNLLNDLYTR FDTLTDSRKN PFVYKVETVG DKYMTVSGLP 
IIIII!IIII IIlIIIIIII IIIIlIIIII IIIIIIIIII IIIIIIIIII 
RA*-CC: HASGEGRMKI VNLLNDLYTR FDTLTDSRKN PFVYKVETVG DKYMTVSGLP 
IIIIiIIIII IIIIII/III lIIIIIIIII IIIIIIIlII IIIIIIIIII 
DO”-GC: “RSGEGAMKI VNLLNDLYTR FDTLTDSRKN PFVYKVETVG DKYMTVSGLP 
437 486 
HSGC-2: EPCIHHARSI CHLALD”MF.1 AGQVQVDGES “QITIGIHTG EWTGVIGQR 
IIIIIIIIII IIIIIIIIII IIIIIIIIIl IIIIIIIIII IIIiIIIIII 
HSGC-I : EPCIHHARSI CHLALDMMEI AGQVQVDGES VQITIGIHTG EWTGVIGQR 
IIIIIIIIlI IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII 
BAT-EC : EPCIHHARSI CHLALDMMEI AGQVQVDGES VQITIGIHTG EWTGVIGQR 
IlIlIlIIII IIIIIIIIII IIIIIIIIII IIlIIIIIII IIIIII/III 
BOV-GC: EPCIHHARSI CHLALDMMEI AGQVQVDGES “QITIGIHTG EWTGVIGQR 
407 536 
HSGC-2: MPRYCLFGN 
IiIIIllII 
HSGC-1 : MPRYCLFGN 
IIlIIIIII 
BAT-GC : MPRYCLFGN 
IIIIIIlll 
BOV-GC : MPRYCLFGN 
537 545 
Fig. I. Comparison of the amino acid sequences for rat (RAT-CC). 
bovine (BOV-GC) and two different forms of human (HSGC-I and 
HSGC-2) soluble guanylate cyclase smaller subunits. The missing 
exon in clone HSGC-2 is marked as horizontal line. 
Koes!ing et al. [2] have reported partial sequences for 
genomic clones of the bovine soluble guanylate cyclase 
enzyme. Koesling et al. [2] show that clone N2 (nucleo- 
tides 1950-2190) has an exon starting at nucleotide 
2154. Upon comparison of our clone I-ISGC-2 with 
clone N2 it is clear that the 99 nucleotides (33 amino 
acids) lacking in HSGC-2 form the beginning of an exon 
in clone N2 [2]. The 5’ splice site GACTAT in the intron 
preceding this exon is very different to the consensus 5’ 
splice site GT(AG)AGT [lo]. Such a different splice site 
may be responsible for its alternative recognition by 
splicing machinery. The HSGC-2 clone product does 
not represent an immature mRNA as it does not have 
anything extra in it; rather it is lacking 33 amino acids. 
From our results it is clear that at least 2 forms of 
soluble guanylate cyclase smaller subunits al-e expressed 
in human lung, one lacking and other having a 99 nucle- 
otide (33 amino acid) exon. It is interesting to note that 
a homologous region to this 33 amino acid sequence is 
present in the membrane-bound form of guanylate cy- 
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clase [l 1,121 where it is located between the protein 
kinase and catalytic domains. It is also notable that the 
HSGC-1 clone is exactly identical to the bovine and rat 
cyclase forms cloned before [1,2]. indicating that the 
soluble enzyme is a very conserved protein. Recently 
Yuen et al. [13] have described a different form of gua- 
nylate cyclase preferentially expressed in rat kidney and 
l.iver. The sequence of this subunit of a guanylate cyclase 
is homologous to the smaller subunit of the soluble 
guanylate cyclase, but it nevertheless hows considera- 
ble diversity. 
In summary we have shown the existence of 2 forms 
of human Iung guanylate cyclase which seem to be gene- 
rated due to alternative splicing. What function these 
alternatively spliced forms play remains to be seen. The 
presence of isoforms of soluble guanylate cyclases may 
potentially give rise to enzymes with different modes of 
regulation of catalytic activity as well as different tissue 
localizations due to differential levels of expression. 
This may find practical uses since soluble guanylate 
cyclases are targets for drugs such as organic nitroesters 
which are in wide use for the treatment of angina pecto- 
ris. 
A~kno,vle~ggcr,fc~nr: Supported by the Swedish MRC (14X-08292) and 
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